Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
The most effective method to Shake Hands During a Pandemic: Wellbeing Tips and Behavior- Fundamental Venture The board Apparatuses for Remote Groups
- 2024's Savvy Home Gadgets for an Associated Way of life
- Little Urban areas to Visit in Western Europe
- Mississippi Insight for Jan. 11, 2026
- The capacity to understand people on a profound level: Exploring Life's Intricacies
- 'Wicked: For Good' was filmed at this surreal National Park in Egypt
- Mom warns of Christmas gift hazard as daughter recovers in hospital
- Kiev declares energy emergency after Russian attacks amid winter cold
